Jessica D. Church
Affiliations: | 2009 | Johns Hopkins University, Baltimore, MD |
Google:
"Jessica Church"Mean distance: (not calculated yet)
Parents
Sign in to add mentorSusan H. Eshleman | grad student | 2009 | Johns Hopkins | |
(Nevirapine resistance in HIV-infected women and infants after exposure to nevirapine-based prophylaxis.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Church JD, Huang W, Mwatha A, et al. (2010) Analysis of HIV tropism in Ugandan infants. Current Hiv Research. 8: 498-503 |
Laeyendecker O, Church JD, Oliver AE, et al. (2010) Pregnancy does not affect HIV incidence test results obtained using the BED capture enzyme immunoassay or an antibody avidity assay. Plos One. 5: e13259 |
Towler WI, Barlow-Mosha L, Church JD, et al. (2010) Analysis of drug resistance in children receiving antiretroviral therapy for treatment of HIV-1 infection in Uganda. Aids Research and Human Retroviruses. 26: 563-8 |
Church JD, Huang W, Parkin N, et al. (2009) Comparison of laboratory methods for analysis of non-nucleoside reverse transcriptase inhibitor resistance in Ugandan infants. Aids Research and Human Retroviruses. 25: 657-63 |
Church JD, Mwatha A, Bagenda D, et al. (2009) In utero HIV infection is associated with an increased risk of nevirapine resistance in ugandan infants who were exposed to perinatal single dose nevirapine. Aids Research and Human Retroviruses. 25: 673-7 |
Hudelson SE, Marlowe N, Huang W, et al. (2009) Analysis of HIV type 1 gp41 and enfuvirtide susceptibility among men in the United States who were HIV infected prior to availability of HIV entry inhibitors. Aids Research and Human Retroviruses. 25: 701-5 |
Church JD, Eshleman SH. (2009) Reply to Krivine et al. Journal of Infectious Diseases. 199: 1554-1555 |
Towler WI, Church JD, Eshleman JR, et al. (2008) Analysis of nevirapine resistance mutations in cloned HIV type 1 variants from HIV-infected Ugandan infants using a single-step amplification-sequencing method (AmpliSeq). Aids Research and Human Retroviruses. 24: 1209-13 |
Church JD, Omer SB, Guay LA, et al. (2008) Analysis of nevirapine (NVP) resistance in Ugandan infants who were HIV infected despite receiving single-Dose (SD) NVP versus SD NVP plus daily NVP up to 6 weeks of age to prevent HIV vertical transmission. The Journal of Infectious Diseases. 198: 1075-82 |
Flys TS, McConnell MS, Matovu F, et al. (2008) Nevirapine resistance in women and infants after first versus repeated use of single-dose nevirapine for prevention of HIV-1 vertical transmission. The Journal of Infectious Diseases. 198: 465-9 |